Medication-info.com Search Menu

Tolvaptan (Jynarque, Samsca): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Boxed warning
Strength:
15 mg, 90 mg, 30 mg, 45 mg, 60 mg
Brand names:
Active ingredient:

Patient information: uses, side effects, how to take - Tolvaptan

What is the most important information I should know about tolvaptan tablets?

Tolvaptan tablets can cause serious side effects, including:

  • Serious liver problems. Tolvaptan tablets can cause serious liver problems that can lead to the need for a liver transplant or can lead to death. Stop taking tolvaptan tablets and call your healthcare provider right away if you get any of the following symptoms:
  • feeling tired
  • fever
  • loss of appetite
  • rash
  • nausea
  • itching
  • right upper stomach (abdomen) pain or tenderness
  • yellowing of the skin and white part of the eye (jaundice)
  • vomiting
  • dark urine

To help reduce your risk of liver problems, your healthcare provider will do a blood test to check your liver:

  • before you start taking tolvaptan tablets
  • at 2 weeks and 4 weeks after you start treatment with tolvaptan tablets
  • then monthly for 18 months during treatment with tolvaptan tablets
  • and every 3 months from then on

It is important to stay under the care of your healthcare provider during treatment with tolvaptan tablets.

Because of the risk of serious liver problems tolvaptan tablets is only available through a restricted distribution program called the tolvaptan tablets Risk Evaluation and Mitigation Strategy (REMS) Program.

  • Before you start treatment with tolvaptan tablets, you must enroll in the tolvaptan tablets REMS Program. Talk to your healthcare provider about how to enroll in the program.
  • Tolvaptan tablets can only be dispensed by a certified pharmacy that participates in the tolvaptan tablets REMS Program. Your healthcare provider can give you information on how to find a certified pharmacy.

What is tolvaptan tablets?

Tolvaptan tablets are a prescription medicine used to slow kidney function decline in adults who are at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).

It is not known if tolvaptan tablets are safe and effective in children.

Do not take tolvaptan tablets if you:

  • have a history of liver problems or have signs or symptoms of liver problems, excluding polycystic liver disease.
  • cannot feel if you are thirsty or cannot replace fluids by drinking.
  • have been told that the amount of sodium (salt) in your blood is too high or too low.
  • are dehydrated.
  • are allergic to tolvaptan or any of the ingredients in tolvaptan tablets. See the end of this Medication Guide for a complete list of ingredients in tolvaptan tablets.
  • are unable to urinate.

Before taking tolvaptan tablets, tell your healthcare provider about all your medical conditions, including if you:

  • have a history of sodium levels that are too low.
  • are pregnant or plan to become pregnant. It is not known if tolvaptan will harm your unborn baby. Tell your healthcare provider if you become pregnant or think that you may be pregnant.

  • are breast-feeding or plan to breastfeed. It is not known if tolvaptan passes into your breast milk. Do not breastfeed during treatment with tolvaptan tablets. Talk to your healthcare provider about the best way to feed your baby during this time.

Tell your healthcare provider about all the medicines you take including prescription medicines, over-the-counter medicines, vitamins and herbal supplements.

  • Taking tolvaptan tablets with certain medicines could cause you to have too much tolvaptan in your blood. Tolvaptan tablets should not be taken with certain medications. Your healthcare provider can tell you if it is safe to take tolvaptan tablets with other medicines.
  • Do not start taking a new medicine without talking to your healthcare provider.
  • Keep a list of your medicines to show your healthcare provider and pharmacist.

How should I take tolvaptan tablets?

  • Take tolvaptan tablets exactly as your healthcare provider tells you to.
  • Take tolvaptan tablets orally two times each day. Take the first dose of tolvaptan tablets when you wake up and take the second dose 8 hours later.
  • Be sure to drink enough water so that you will not get thirsty or become dehydrated.
  • If you miss a dose of tolvaptan tablets, take the next dose at your regular time.
  • If you take too much tolvaptan tablets, call your healthcare provider or go to the nearest hospital emergency room right away.

What should I avoid while taking tolvaptan tablets?

  • Do not drink grapefruit juice during treatment with tolvaptan tablets. This could cause you to have too much tolvaptan in your blood.

What are the possible side effects of tolvaptan tablets?

Tolvaptan tablets may cause serious side effects, including:

See “What is the most important information I should know about tolvaptan tablets?”

  • Too much sodium in your blood (hypernatremia) and loss of too much body fluid (dehydration). In some cases, dehydration can lead to extreme loss of body fluid called hypovolemia. You should drink water when you are thirsty and throughout the day and night. Stop taking tolvaptan tablets and call your healthcare provider if you cannot drink enough water for any reason, such as not having access to water, or vomiting or diarrhea. Tell your healthcare provider if you get any of the following symptoms:

    • dizziness
    • fainting
    • weight loss
    • a change in the way your heart beats
    • feel confused or weak

    The most common side effects of tolvaptan tablets include:

  • thirst and drinking more fluid than normal
  • making large amounts of urine, urinating often and urinating at night

These are not all the possible side effects of tolvaptan tablets.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store tolvaptan tablets?

Tolvaptan tablets comes in a child-resistant package. Store tolvaptan tablets between 68°F to 77°F (20°C to 25°C).

Keep tolvaptan tablets and all medicines out of the reach of children.

General information about the safe and effective use of tolvaptan tablets.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use tolvaptan tablets for a condition for which it was not prescribed. Do not give tolvaptan tablets to other people, even if they have the same symptoms you have. It may harm them.

What are the ingredients in tolvaptan tablets?

Active ingredient: tolvaptan

Inactive ingredients: croscarmellose sodium, corn starch, FD&C Blue No. 2 Aluminium lake, hypromellose 2910, lactose monohydrate, magnesium stearate and microcrystalline cellulose.

Manufactured by:

Alkem Laboratories Ltd.,

Mumbai - 400 013, INDIA.

Distributed by:

Ascend Laboratories, LLC

Bedminster, NJ 07921

For more information, call 1-877-272-7901.

This Medication Guide has been approved by the U.S. Food and Drug Administration.

Revised: 3/2026

PT4124

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 220147 · View the label on DailyMed

Revision date stated in the text: March 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Tolvaptan

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Boxed warning Yes – this drug has a boxed warning (also called a black box warning), the strongest warning of the FDA.
Drug class Vasopressin V2 Receptor Antagonist
Active ingredient Tolvaptan
Dosage form Tablet, Kit
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) ALKEM LABS LTD
FDA approval ANDA 220147Abbreviated New Drug Application (ANDA) – generic drug Approved April 21, 2026
Therapeutic equivalence (TE) code AB2Codes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Generics Samsca with the same TE code
Manufacturers 8 labelers list this drug on DailyMed
Packages (NDC)
Package
15 mg – 30 in 1 bottle NDC 67877-915-30
90 mg, 30 mg – 1 in 1 blister pack / 4 in 1 carton NDC 67877-924-14
30 mg – 30 in 1 bottle NDC 67877-916-30
45 mg – 30 in 1 bottle NDC 67877-917-30
60 mg – 30 in 1 bottle NDC 67877-918-30
90 mg – 30 in 1 bottle NDC 67877-919-30
15 mg – 1 in 1 blister pack / 4 in 1 carton NDC 67877-920-14
30 mg, 15 mg – 1 in 1 blister pack / 4 in 1 carton NDC 67877-921-14
45 mg, 15 mg – 1 in 1 blister pack / 4 in 1 carton NDC 67877-922-14
60 mg, 30 mg – 1 in 1 blister pack / 4 in 1 carton NDC 67877-923-14

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.